Monoclonal gammopathy of undetermined significance [MGUS]
Benign monoclonal gammopathy
Hypogammaglobulinemia co-occurrent and due to monoclonal gammopathy of undetermined significance
Monoclonal gammopathy clinical)
Monoclonal gammopathy of uncertain significance
Monoclonal gammopathy of undetermined significance w hypogammaglobulinemia
Monoclonal gammopathy, benign
Monoclonal gammopathy, undetermined significance
Monoclonal paraproteinemia
A benign condition in which there is a higher-than-normal level of a protein called m protein in the blood. Patients with mgus are at an increased risk of developing cancer.
A laboratory test result indicating the presence of an abnormally high level of monoclonal immunoglobulins in the blood or urine.
A plasma cell disorder in which an abnormal amount of a single immunoglobulin is present in the serum. Up to 25% of cases of monoclonal gammopathy of undetermined significance mgus) progress to a b-cell malignancy or myeloma. Mgus may occur in conjunction with various carcinomas, chronic inflammatory and infectious conditions, and other diseases.
Conditions characterized by the presence of m protein monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia.
D47.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM D47.2 became effective on October 1, 2022.
This is the American ICD-10-CM version of D47.2 – other international versions of ICD-10 D47.2 may differ.